This test is most useful if any of these apply to you.
Your adult height is one of the few numbers on your chart that was mostly settled by late adolescence. It is a quiet record of your childhood: your genes, the hormones that drove your growth, and how well you were fed and how healthy you were in your early years.
What makes it worth a second look is that it tilts your odds for specific diseases, and it tilts them in opposite directions. On average, shorter people carry more heart disease and diabetes but less cancer. Taller people tend to get the reverse. Later in life, watching your height fall becomes one of the simplest ways to catch a spine fracture you might not feel.
Height comes from the growth plates, the zones of cartilage at the ends of a child's long bones where new bone is added until they fuse in the late teens. The main growth signals are growth hormone and IGF-1. Growth hormone comes from the pituitary gland at the base of the brain. IGF-1 is a growth messenger made mostly in the liver in response to it.
Genes set much of the ceiling. Large genetic studies have found more than 12,000 common DNA variants linked to height, which is why height runs in families and comes from both parents, not one. But that genetic potential only gets reached if the growth years go well. This is why height also works as a marker of early-life nutrition and disease burden, and why populations get taller as childhood conditions improve. The test measures how tall you stand today; it reflects that whole childhood story.
The clearest finding in this field is that shorter people have more cardiovascular disease. Pooling 17 studies covering about 2.7 million people, the tallest group had roughly a fifth fewer cardiovascular deaths than the shortest, and about a quarter fewer stroke deaths. A separate individual-data meta-analysis of about a million people found that each several-inch step up in height came with slightly lower risk of dying from heart or blood-vessel disease. This held after accounting for weight, blood pressure, cholesterol, diabetes, and social factors.
There is a catch. In a study spanning 21 countries, the protective link between being taller and avoiding heart disease was strong in low-income countries but faded to almost nothing in higher-income ones. That points back to childhood: where kids grow up healthier and heart disease is treated well, adult height stops carrying the same signal.
For you: your height does not set your heart risk in stone, and you cannot change it. Treat a shorter stature as a nudge to be aggressive about the levers you can move, especially ApoB, blood pressure, and blood sugar. ApoB is a count of the cholesterol particles that clog arteries.
Height runs the other way for cancer: taller means more of it. In 1.3 million women followed for years, each roughly four inches of extra height came with about 16% higher risk of cancer overall, and the pattern showed up across ten separate cancers including breast, bowel, and kidney. Melanoma stood out at about a third higher. A Swedish study of 5.5 million people found the same direction, with the strongest signal again for melanoma.
The likely reason is simple arithmetic. A taller body has more cells, so there are more chances for one of them to turn cancerous. The same childhood growth signals that added inches, including higher IGF-1, may also push cells to divide, though that pathway is still a hypothesis rather than a proven cause. This is a broad statistical tilt, not a diagnosis. Most tall people never get cancer.
For you: if you are on the taller end, the useful response is not worry but diligence with the screening that already exists. Stay current on colon, breast, cervical, or prostate screening when appropriate, and take skin changes seriously, especially if you have melanoma risk factors.
Shorter stature also tracks with more type 2 diabetes. Pooling 16 studies, taller people had roughly 12% lower risk. In a German cohort of 783,000 people, each four inches shorter came with about 15% higher diabetes risk in women and about 10% in men. Part of this seems to run through the liver: when researchers accounted for liver fat and related markers, much of the height link shrank, which suggests shorter people may carry more of the metabolic fat that drives diabetes. The German study found no link with type 1 diabetes.
A few conditions get more common with height rather than less. Taller people have more venous blood clots: in a combined Norwegian cohort of 114,567 people, each four inches of height raised clot risk by about a third in men and about a quarter in women. Studies using genetic markers of height point the same way, so height itself, not just the habits of tall people, appears to be part of the cause. The leading idea is plumbing: blood has to travel farther up longer leg veins against gravity, where it can pool and clot. Being taller also comes with somewhat higher rates of atrial fibrillation and aortic aneurysm. Atrial fibrillation is an irregular heartbeat. An aortic aneurysm is a dangerous widening of the body's main artery.
It is tempting to ask whether taller or shorter is better. That is the wrong question. Height is not a score you want high or low; it is a marker of a physical type, and different types carry different risks for different diseases. The same number can point one way for heart disease and the other way for cancer or clots. Read your height as a map of where to aim your prevention, not as a grade. One meta-analysis found overall death risk was lowest somewhere in the middle, around 174 cm for men and 158 cm for women, with a small penalty at both extremes.
This part is actionable. Your adult height barely changes for decades, so a single reading is a fixed risk map, not something to track month to month. What is worth tracking is the slow loss that starts around age 30 and speeds up later, averaging a few centimeters by 70 in men and more in women. Most of that is the spine settling, but a sudden or steep drop can mean a vertebral fracture, the kind of quiet spinal break that often causes no obvious pain.
In a large prospective study, people losing more than half a centimeter a year had about 76% higher risk of any fracture and roughly double the risk of a hip fracture. Osteoporosis guidelines use height loss of more than about 2 cm over a few years, or 4 cm from your peak young-adult height, as a reason to image the spine. The case for retesting is bone health, not reranking your disease odds.
If you have measurably lost height, confirm it with a careful repeat measurement. If the drop is real, especially more than a couple of centimeters over a few years, order a bone density scan and spine imaging to check for a compression fracture. Real height loss plus low bone density should trigger action on osteoporosis rather than watchful waiting.
For a child whose growth is crossing downward across the percentile lines on a growth chart, the workup starts with IGF-1, thyroid tests, and a celiac screen, and often a pediatric endocrinologist. For yourself, use your height as context for the rest of your panel: shorter with a family history of early heart disease means push hard on cholesterol and blood pressure; taller means stay current on cancer screening.
Evidence-backed interventions that affect your Height level
Height is best interpreted alongside these tests.